MedTrace Logo

Flucelvax Pregnancy Registry

NCT02258178 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2017-10-05

No results posted yet for this study

Summary

The goal of the registry is to develop a better understanding of the safety of Flucelvax in women and their offspring who were exposed to the vaccine during pregnancy

Conditions

  • Pregnant Women, Influenza

Interventions

BIOLOGICAL

Flucelvax (cTIV)

vaccine exposure in routine care (no vaccination per protocol)

Sponsors & Collaborators

  • Seqirus

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2020-06-30
Completion
2020-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02258178 on ClinicalTrials.gov